Massimo Vitale

17.8k total citations · 7 hit papers
108 papers, 14.8k citations indexed

About

Massimo Vitale is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Massimo Vitale has authored 108 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Immunology, 32 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Massimo Vitale's work include Immune Cell Function and Interaction (97 papers), T-cell and B-cell Immunology (69 papers) and CAR-T cell therapy research (24 papers). Massimo Vitale is often cited by papers focused on Immune Cell Function and Interaction (97 papers), T-cell and B-cell Immunology (69 papers) and CAR-T cell therapy research (24 papers). Massimo Vitale collaborates with scholars based in Italy, United States and Belgium. Massimo Vitale's co-authors include Lorenzo Moretta, Alessandro Moretta, Cristina Bottino, Claudia Cantoni, Daniela Pende, Maria Cristina Mingari, Roberto Biassoni, Simona Sivori, Raffaella Augugliaro and Mariella Della Chiesa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Massimo Vitale

105 papers receiving 14.5k citations

Hit Papers

Activating Receptors and ... 1995 2026 2005 2015 2001 1996 2003 1997 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
    2001 1.4k citations Alessandro Moretta, Cristina Bottino et al. profile →
  2. RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
    1996 749 citations Alessandro Moretta, Cristina Bottino et al. profile →
  3. Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule
    2003 705 citations Cristina Bottino, Roberta Castriconi et al. The Journal of Experimental Medicine profile →
  4. Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor
    1997 639 citations Hideyuki Ikeda, Bernard Lethé et al. Immunity profile →
  5. NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis
    1998 590 citations Massimo Vitale, Cristina Bottino et al. The Journal of Experimental Medicine profile →
  6. Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells
    2003 574 citations Roberta Castriconi, Claudia Cantoni et al. Proceedings of the National Academy of Sciences profile →
  7. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
    1995 500 citations Roberto Biassoni, Claudia Cantoni et al. Immunity profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Massimo Vitale 13.4k 4.1k 1.5k 1.4k 916 108 14.8k
Claudia Cantoni 10.3k 0.8× 3.3k 0.8× 1.1k 0.8× 973 0.7× 746 0.8× 110 11.6k
Roberto Biassoni 13.2k 1.0× 3.1k 0.8× 1.3k 0.9× 1.5k 1.1× 992 1.1× 168 14.4k
Cristina Bottino 19.1k 1.4× 5.3k 1.3× 1.7k 1.2× 2.1k 1.6× 1.3k 1.4× 186 20.9k
Klas Kärre 12.9k 1.0× 3.3k 0.8× 1.8k 1.2× 1.1k 0.8× 1.4k 1.6× 180 14.7k
Adelheid Cerwenka 8.3k 0.6× 3.7k 0.9× 1.6k 1.1× 654 0.5× 1.1k 1.2× 115 10.4k
Daniela Pende 15.7k 1.2× 4.6k 1.1× 1.3k 0.9× 3.6k 2.6× 1.2k 1.3× 179 17.3k
Megan A. Cooper 8.8k 0.7× 2.5k 0.6× 808 0.5× 1.1k 0.8× 960 1.0× 84 10.0k
Todd A. Fehniger 11.6k 0.9× 4.2k 1.0× 1.6k 1.1× 2.0k 1.5× 1.3k 1.4× 189 14.1k
Simona Sivori 8.7k 0.6× 2.5k 0.6× 817 0.6× 1.1k 0.8× 754 0.8× 101 9.5k
Karl‐Johan Malmberg 7.4k 0.5× 2.9k 0.7× 977 0.7× 1.1k 0.8× 1.1k 1.2× 124 8.5k

Countries citing papers authored by Massimo Vitale

Since Specialization
Citations

This map shows the geographic impact of Massimo Vitale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Vitale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Vitale more than expected).

Fields of papers citing papers by Massimo Vitale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Vitale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Vitale. The network helps show where Massimo Vitale may publish in the future.

Co-authorship network of co-authors of Massimo Vitale

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Vitale. A scholar is included among the top collaborators of Massimo Vitale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Vitale. Massimo Vitale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carlomagno, Simona, Michela Falco, Claudia Cantoni, et al.. (2025). CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors. Frontiers in Immunology. 16. 1481745–1481745. 2 indexed citations
2.
Kim, Jin-Hyun, et al.. (2025). Efficacy of high-intensity focused ultrasound for treating upper and lower eyelid sagging. JPRAS Open. 48. 147–154.
3.
Lopez, Manuela, Monica Parodi, Stefano Persano, et al.. (2025). CD56bright cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cells. Journal for ImmunoTherapy of Cancer. 13(2). e010205–e010205. 3 indexed citations
4.
Cantoni, Claudia, Michela Falco, Massimo Vitale, et al.. (2024). Human NK cells and cancer. OncoImmunology. 13(1). 2378520–2378520. 13 indexed citations
5.
Parodi, Monica, Giovanni Centonze, Paola Orecchia, et al.. (2024). Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells. Journal for ImmunoTherapy of Cancer. 12(3). e007895–e007895. 11 indexed citations
6.
Carrega, Paolo, Lodovica Zullo, Chiara Dellepiane, et al.. (2022). Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. Cancers. 14(20). 5046–5046. 14 indexed citations
7.
Huergo-Zapico, Leticía, Monica Parodi, Claudia Cantoni, et al.. (2018). NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines. Cancer Research. 78(14). 3913–3925. 59 indexed citations
8.
Cantoni, Claudia, Leticía Huergo-Zapico, Monica Parodi, et al.. (2016). NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?. Journal of Immunology Research. 2016. 1–13. 70 indexed citations
9.
Pietra, Gabriella, Claudia Manzini, Silvia Rivara, et al.. (2012). Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity. Cancer Research. 72(6). 1407–1415. 249 indexed citations
10.
Gattazzo, Cristina, Antonella Teramo, Marta Miorin, et al.. (2010). Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes. Haematologica. 95(10). 1722–1729. 20 indexed citations
11.
Sivori, Simona, Michela Falco, Mariella Della Chiesa, et al.. (2004). CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proceedings of the National Academy of Sciences. 101(27). 10116–10121. 368 indexed citations
12.
Castriconi, Roberta, Claudia Cantoni, Mariella Della Chiesa, et al.. (2003). TGFβ1 inhibits the surface expression of the NKp30 and NKG2D triggering NK receptors: consequences for the NK-mediated killing of dendritic cells. Italian Journal of Anatomy and Embryology. 42–42. 1 indexed citations
13.
Ikeda, Hideyuki, Bernard Lethé, Frédéric Lehmann, et al.. (1997). Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor. Immunity. 6(2). 199–208. 639 indexed citations breakdown →
14.
Sivori, Simona, Massimo Vitale, Luigia Morelli, et al.. (1997). p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation. The Journal of Experimental Medicine. 186(7). 1129–1136. 420 indexed citations
15.
Moretta, Alessandro, Massimo Vitale, Simona Sivori, et al.. (1996). Inhibitory and Activatory Receptors for HLA Class I Molecules in Human Natural Killer Cells. Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 64. 77–87. 8 indexed citations
16.
Biassoni, Roberto, Claudia Cantoni, Michela Falco, et al.. (1996). The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.. The Journal of Experimental Medicine. 183(2). 645–650. 305 indexed citations
17.
Moretta, Alessandro, Massimo Vitale, Simona Sivori, et al.. (1994). Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.. The Journal of Experimental Medicine. 180(2). 545–555. 174 indexed citations
18.
Pucillo, Carlo, et al.. (1993). Interactions of promonocytic U937 cells with proteins of the extracellular matrix.. PubMed. 80(2). 248–52. 20 indexed citations
19.
20.
Poggi, Alessandro, Ruggero Pardi, Nicoletta Pella, et al.. (1993). CD45‐mediated regulation of LFA1 function in human natural killer cells. Anti‐CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. European Journal of Immunology. 23(10). 2454–2463. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Cantoni Breakdown of academic impact, for papers by Roberto Biassoni Breakdown of academic impact, for papers by Cristina Bottino Breakdown of academic impact, for papers by Klas Kärre Breakdown of academic impact, for papers by Adelheid Cerwenka Breakdown of academic impact, for papers by Daniela Pende Breakdown of academic impact, for papers by Megan A. Cooper Breakdown of academic impact, for papers by Todd A. Fehniger Breakdown of academic impact, for papers by Simona Sivori Breakdown of academic impact, for papers by Karl‐Johan Malmberg
Rankless by CCL
2026